Now playing
01:49
Why this pot investor compares cannabis today to the end of Prohibition
Now playing
00:00
These pot stocks are poised to win big under Biden
Shutterstock
Now playing
04:50
The vaping crisis has been terrible for legal weed companies
LOS ANGELES, CALIFORNIA - JUNE 04: Drake attends the LA Premiere Of HBO's "Euphoria" at The Cinerama Dome on June 04, 2019 in Los Angeles, California. (Photo by Frazer Harrison/Getty Images)
Frazer Harrison/Getty Images North America/Getty Images
LOS ANGELES, CALIFORNIA - JUNE 04: Drake attends the LA Premiere Of HBO's "Euphoria" at The Cinerama Dome on June 04, 2019 in Los Angeles, California. (Photo by Frazer Harrison/Getty Images)
Now playing
00:54
Drake launches cannabis company
Now playing
00:55
Bruce Linton says Canopy Growth terminated him
Section grower Corey Evans walks between flowering marijuana plants at the Canopy Growth Corporation facility in Smiths Falls, Ontario, Canada, January 4, 2018. Picture taken January 4, 2018. To match Insight CANADA-MARIJUANA/INNOVATION   REUTERS/Chris Wattie
Chris Wattie/Reuters
Section grower Corey Evans walks between flowering marijuana plants at the Canopy Growth Corporation facility in Smiths Falls, Ontario, Canada, January 4, 2018. Picture taken January 4, 2018. To match Insight CANADA-MARIJUANA/INNOVATION REUTERS/Chris Wattie
Now playing
03:10
Why cannabis stocks are soaring
Now playing
01:36
His business is alcohol, but he sees a future in cannabis
Canopy Growth CEO Bruce Linton hands Ian Power, who is first in line to purchase the first legal recreational marijuana after midnight, his purchases at a Tweed retail store in St John's, Newfoundland and Labrador, Canada October 17, 2018.  REUTERS/Chris Wattie
Chris Wattie/Reuters
Canopy Growth CEO Bruce Linton hands Ian Power, who is first in line to purchase the first legal recreational marijuana after midnight, his purchases at a Tweed retail store in St John's, Newfoundland and Labrador, Canada October 17, 2018. REUTERS/Chris Wattie
Now playing
01:37
Marijuana is now legal across Canada
An Israeli agricultural engineer inspects marijuana plants at the BOL (Breath Of Life) Pharma greenhouse in the country's second-largest medical cannabis plantation, near Kfar Pines in northern Israel, on March 9, 2016.
The recreational use of cannabis is illegal in the Jewish state, but for the past 10 years its therapeutic use has not only been permitted but also encouraged. Last year, doctors prescribed the herb to about 25,000 patients suffering from cancer, epilepsy, post-traumatic stress and degenerative diseases. The purpose is not to cure them but to alleviate their symptoms. Forbidden to export its cannabis plants, Israel is concentrating instead on marketing its agronomic, medical and technological expertise in the hope of becoming a world hub in the field.
 / AFP / JACK GUEZ        (Photo credit should read JACK GUEZ/AFP/Getty Images)
JACK GUEZ/AFP/Getty Images
An Israeli agricultural engineer inspects marijuana plants at the BOL (Breath Of Life) Pharma greenhouse in the country's second-largest medical cannabis plantation, near Kfar Pines in northern Israel, on March 9, 2016. The recreational use of cannabis is illegal in the Jewish state, but for the past 10 years its therapeutic use has not only been permitted but also encouraged. Last year, doctors prescribed the herb to about 25,000 patients suffering from cancer, epilepsy, post-traumatic stress and degenerative diseases. The purpose is not to cure them but to alleviate their symptoms. Forbidden to export its cannabis plants, Israel is concentrating instead on marketing its agronomic, medical and technological expertise in the hope of becoming a world hub in the field. / AFP / JACK GUEZ (Photo credit should read JACK GUEZ/AFP/Getty Images)
Now playing
02:28
Why weed is stuck in a legal limbo
Now playing
03:34
Canopy Growth co-CEO explains deal with Acreage
Now playing
05:27
Canopy Growth co-CEO: Product opportunity is 'substantial'
Now playing
06:11
Cronos CEO: 'Watershed moment' for marijuana
Now playing
03:48
Canopy Growth CEO optimistic the US market could open up
CNN
Now playing
02:17
Cannabis comes to Fifth Avenue
(CNN Business) —  

Harborside, an Oakland-based dispensary operator lionized as a pioneer in California’s cannabis industry, overhauled its executive team and ousted its CEO in an effort to spur growth, the company announced on Monday.

Andrew Berman, Harborside’s CEO since February 2018, helped steer the company through a $150 million reverse merger and public listing on the Canadian Securities Exchange in June. The company had grand ambitions for expansion in the Golden State.

Harborside’s timing for the public listing wasn’t the best.

During the past few months, capital markets have softened and the public markets in particular have been outright brutal to cannabis firms. Shares of Harborside are trading at $1.10, down from a high of $4.18 in mid-June.

Cannabis companies large and small are scrapping mergers, shedding jobs, scaling back on expansion plans, and switching out their CEOs. In this month alone, firms such as Weedmaps and Hexo announced the layoffs of hundreds of employees; and a blockbuster deal between PharmaCann and MedMen was called off.

Harborside held off on plans to acquire two California dispensary companies, Berman told CNN Business earlier this month.

“Given the changing and challenging market conditions, the board believes a new and broader leadership team is necessary to accelerate the growth of the company,” Harborside said in a statement released Monday morning.

Peter Bilodeau, Harborside’s chairman, will serve as interim CEO while the company searches for a permanent replacement.

Harborside filled out its executive team by promoting Greg Sutton, former vice president of finance, to the role of chief operating officer; and hiring Lisah Poore, a former executive with Dosist and Sephora, as chief retail officer; and Mireille Duclos, a former human resources executive with Nestle and Sears, to lead HR.

Sutton and Duclos will spearhead cost-cutting initiatives, according to Harborside’s announcement.

Harborside executives and Berman could not be immediately reached for comment.